Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,140,683 papers from all fields of science
Search
Sign In
Create Free Account
bekanamycin
Known as:
aminodeoxykanamycin
, kanamycin B
, kanendomycin
An aminoglycoside antibiotic derived from Streptomyces kanamyceticus, with antibacterial activity. Bekanamycin irreversibly binds to the bacterial…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Anti-Bacterial Agents
Kanamycin
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Chiral phosphoric acid-catalyzed desymmetrizative glycosylation of 2-deoxystreptamine and its application to aminoglycoside synthesis.
Jeonghyo Lee
,
Alina Borovika
,
Y. Khomutnyk
,
P. Nagorny
Chemical Communications
2017
Corpus ID: 206067141
This work describes chiral phosphoric acid (CPA)-catalyzed desymmetrizative glycosylation of meso-diol derived from 2…
Expand
2009
2009
Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents.
Zhong-Cheng Song
,
Gaofeng Ma
,
Pengcheng Lv
,
Huan-qiu Li
,
Zhu-Ping Xiao
,
Hailiang Zhu
European journal of medicinal chemistry
2009
Corpus ID: 20726519
2004
2004
Application of glycodiversification: expedient synthesis and antibacterial evaluation of a library of kanamycin B analogues.
Jie Li
,
Jinhua Wang
,
+4 authors
C. Chang
Organic Letters
2004
Corpus ID: 37704585
[reaction: see text] The expedient synthesis of a library of kanamycin B analogues is reported. The revealed SAR will guide…
Expand
1993
1993
Study on fluorination-toxicity relationships. Syntheses of 1-N-[(2R,3R)- and (2R,3S)-4-amino-3-fluoro-2-hydroxybutanoyl] derivatives of kanamycins.
Y. Takahashi
,
C. Ueda
,
T. Tsuchiya
,
Y. Kobayashi
Carbohydrate Research
1993
Corpus ID: 38251447
1989
1989
Depression of calcium current at mouse motor nerve endings by polycationic antibiotics
C. Bourret
,
A. Mallart
Brain Research
1989
Corpus ID: 7125158
1978
1978
In Vitro Comparison of Kanamycin, Kanendomycin, Gentamicin, Amikacin, Sisomicin, and Dibekacin Against 200 Strains of Pseudomonas aeruginosa
A. Paradelis
,
J. Douboyas
,
G. Stathopoulos
,
A. Grigoriadou-Edipides
,
C. Triantaphylidis
,
J. Papapanagiotou
Antimicrobial Agents and Chemotherapy
1978
Corpus ID: 10159387
The antimicrobial activity of kanamycin, kanendomycin, gentamicin, amikacin, sisomicin, and dibekacin against 200 strains of…
Expand
1976
1976
Neuromuscular blocking activity of aminoglycoside antibiotics.
Paradelis Ag
,
Triantaphyllidis Cj
,
G. Logaras
1976
Corpus ID: 201891111
Neuromuscular blockade is a recognized complication of anti -microbial therapy.There are now many experimental and clinical…
Expand
1972
1972
Purification and properties of dihydrostreptomycin-phosphorylating enzyme from Pseudomonas aeruginosa.
Fujio Kobayashi
,
M. Yamaguchi
,
Junko Sato
,
Susumu Mitsuhashi
Japanese Journal of Microbiology
1972
Corpus ID: 32189188
The distribution of the dihydrostreptomycin (DHSM)-phosphorylating enzyme was investigated using DHSM-resistant strains of…
Expand
1971
1971
Phosphorylated inactivation of aminoglycosidic antibiotics by Pseudomonas aeruginosa.
Fujio Kobayashi
,
M. Yamaguchi
,
Susumu Mitsuhashi
Japanese Journal of Microbiology
1971
Corpus ID: 35193160
The studies were conducted on the inactivation of aminoglycosidic antibiotics including a new antibiotic, lividomycin, by a cell…
Expand
1962
1962
Changes produced by kanamycin. Early histologic manifestations in the inner ears of cats.
J. Reddy
,
M. Igarashi
A M A Archives of Otolaryngology
1962
Corpus ID: 29076190
Since the discovery of kanamycin in 1957, 1 this antibiotic has been used clinically in conditions often treated with…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE